Stock Market

Li Auto shares dive as underwhelming revenue forecast offsets Q4 beat

Investing | Fri, Mar 14 2025 08:51 PM AEDT

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

Investing.com -- Li Auto (NASDAQ:LI)'s U.S.-listed shares slid nearly 4% in premarket trading Friday after the Chinese electric vehicle (EV) maker issued a revenue forecast that significantly missed analyst expectations, overshadowing its fourth-quarter beat.

For the fiscal Q4 of 2024, the company reported earnings per share (EPS) of RMB3.79, trumping analyst estimates of RMB2.82. Revenue for the period rose 6.1% year-over-year (YoY) to RMB44.27 billion, also exceeding the consensus estimate of RMB43.48 billion.

Li Auto delivered 158,696 vehicles in Q4, marking a 20% increase YoY but falling short of the expected 164,919 units. Vehicle sales totaled RMB42.64 billion, up 5.6% from the previous year and surpassing the RMB39.86 billion estimate.

Gross margin came in at 20.3%, down from 23.5% YoY and below the 21.2% estimate.

“Our record performance in the fourth quarter propelled our full-year deliveries to surpass the 500,000 milestone, making us the first among premium automotive brands in China," commented Mr. Xiang Li, chairman and CEO of Li Auto. "We also maintained our sales leadership position among Chinese automotive brands in the RMB200,000 and above NEV market."

"Looking ahead to 2025, we will launch our next-generation autonomous driving architecture and new BEV models, bringing happiness to more families with enhanced intelligent features and a more diversified product portfolio," he added.

Triggering the negative investor reaction was Li Auto's forecast for the first quarter of fiscal 2025. The EV maker expects revenue between RMB23.4 billion and RMB24.7 billion in Q1, significantly lower than the consensus estimate of RMB35.44 billion.

This article first appeared in Investing.com

Market Updates

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

UroShield Cited as Effective in Preventing CAUTIs and Blockages, Having a Major Impact on Quality of Life and Reducing Healthcare ...

Business Wire | Sat, Mar 15 2025 02:00 AM AEDT

Read More
Stock Market

Ulta Beauty shares jump after results top estimates amid strong holiday demand

Investing.com - Shares in Ulta Beauty (NASDAQ:ULTA) surged in premarket U.S. trading on Friday after the cosmetics ...

Investing | Sat, Mar 15 2025 12:13 AM AEDT

Read More
Stock Market

American Express rating raised at Baird following persistent market sell-off

Investing.com -- Baird analysts upgraded American Express (NYSE:AXP) to Neutral following a “persistent sell-off in the broader market” ...

Investing | Sat, Mar 15 2025 12:11 AM AEDT

Read More
Stock Market

UBS warns $14tn in U.S. assets is at risk amid fading exceptionalism

Investing.com -- UBS analysts warned in a note Friday that “fading US exceptionalism” could put “~$14tn of unhedged US ...

Investing | Sat, Mar 15 2025 12:03 AM AEDT

Read More
Stock Market

S&P 500 rallies will likely be sold until Trump or the Fed pivot: Barclays

Investing.com -- Despite improved technicals that could support short-term rebounds, "rallies will likely be sold until Trump or the ...

Investing | Fri, Mar 14 2025 11:35 PM AEDT

Read More